GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (FRA:MDG1) » Definitions » Tax Provision

Medigene AG (FRA:MDG1) Tax Provision : €-0.31 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Medigene AG Tax Provision?

Medigene AG's tax provision for the six months ended in Jun. 2024 was €0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.31 Mil.

Medigene AG Tax Provision Historical Data

The historical data trend for Medigene AG's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Tax Provision Chart

Medigene AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.47 0.30 1.04 0.42

Medigene AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 1.60 0.73 -0.31 -

Medigene AG Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigene AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (FRA:MDG1) » Definitions » Tax Provision
Comparable Companies
FRA:D89 FRA:T5O0 XTER:HPHA OCSE:NOVO B REGN VRTX ASX:CSL XKRX:207940 ALNY XBRU:UCB XKRX:068270 MRNA XBRU:ARGX BGNE BNTX OCSE:GMAB BMRN UTHR INSM SRPT
Traded in Other Exchanges
0QGJ:UK MDG1:Germany MDG1:Austria
Address
Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Website
https://www.medigene.com
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG Headlines

No Headlines